Corporate offices within Johnson and Johnson responsible for the identification and nurturing of emerging technologies related to healthcare and the facilitation of the incorporation of these technologies into the Johnson & Johnson Family of Companies. Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, for the consumer, pharmaceutical, and medical devices and diagnostics markets.

Ethicon is one of the leading medical device companies within the Johnson & Johnson Family of Companies. With a global market leadership in surgical sutures for more than a century, Ethicon has expanded its product portfolio into wound management, women's health, and cardiovascular surgery. Johnson & Johnson is the world's most comprehensive and broadly based manufacturer of health care products, for the consumer, pharmaceutical, and medical devices and diagnostics markets.

Gynecare, Inc., (now a part of the Ethicon Women's Health and Urology) is a division of Ethicon, Inc., and a leader in minimally invasive gynecological health solutions. Gynecare's products have enhanced the lives of 1.5 million women worldwide.

Johnson & Johnson Development Corporation (JJDC) is the venture capital arm of Johnson & Johnson, with a primary focus on private equity investments in early stage companies that are of strategic interest to the Johnson & Johnson Family of Companies. JJDC's portfolio includes emerging companies in the fields of pharmaceuticals, biotechnology, medical devices, diagnostics and consumer products.

QUALCOMM, Inc., is a global market leader in developing and delivering innovative digital wireless communications products and services based on CDMA and other advanced technologies. QUALCOMM has been leading innovations in, among other fields, the convergence of wireless technologies and healthcare product solutions.

Seed stage venture capital fund focused on investments in break through cross-disciplinary innovations. Michael Borrus, the founding General Partner of X/Seed, previously served as an Executive in Residence at Mohr Davidow Ventures, a Tier 1 venture capital firm based in Silicon Valley with over twenty years of track record in investing in the areas of information technology, energy, materials, and life sciences.

Boutique private equity fund focused on investments in wireless technologies and life sciences.

International merchant bank with investments in renewable energy, materials, new media and the life sciences.

A subsidiary of Boston Equities, Inc., Boston Health Group, Inc., is a private equity fund focused on investment and nurturing of early stage medical device and biotechnology companies.

Optiscan (ASX: OIL) is a publicly traded Australian company and a global market leader in the development and application of microscopic imaging technologies for medical markets. Optiscan is actively developing and commercializing miniaturized in-vivo real time confocal microscopes for applications in flexible and rigid endoscopy, and bench top scientific research.

FeRx was a privately held, product-oriented, targeted drug delivery company dedicated to the development and commercialization of its proprietary magnetically targeted carrier (MTC) technology, in combination with Doxorubicin for the targeted treatment of select cancerous tumors such as hepatocellular carcinomas and metastatic liver disease. FeRx was wound down after equivocal results from its multi-center pivotal clinical trial.

The Center for Biophotonics, Science and Technology (CBST) is a National Science Foundation sponsored center of excellence established for the advancement of the field of medical Optics. CBST’s goal is to advance biomedicine and photonics engineering – by focusing its intellectual, scientific, educational and industrial outreach efforts on the rapid and directed development of biophotonics technology. CBST coordinates activities within its core group of eight university campuses, led by University of California, Davis, and one national laboratory, and is building an extensive worldwide network of schools, industrial partners, and other biophotonics research centers.

SIFI is a privately held developer and manufacturer of, and European market leader in, ophthalmic products. SIFI has a broad pipeline of products from diagnostic products, to surgical and pharmaceutical products all for diagnosis, management, or treatment of eye diseases.

eVision is a development stage company that has invented and is developing smart dynamic optics. The company's proprietary technology has evolved into a platform of optical solutions that have potential for numerous applications such as electro-active spectacles, electro-active intra-ocular lenses, electro-active contact lenses, beam steering of light, electro-active medical diagnostic equipment, military applications, and SuperVision correction.

Privately held, venture backed, development stage biotechnology company focused on the development of a proprietary technology using a chemical genomics approach to develop or re-engineer small molecule drugs with reduced toxicity and improved clinical characteristics.

Privately held development stage company focused on the development, manufacturing, and commercialization of novel nanotechnology based materials such as single sheet graphene, carbon nanotubes, and fullerenes for medical and industrial applications.

PhiloMetron is a development stage company developing proprietary, distributed wireless human sensing technologies for applications in cardiovascular medicine, wound care, and other major healthcare markets.

A privately held development stage biotechnology company focused on the development and commercialization of virus-like particle vaccine and immunotherapy products for the treatment and prevention of certain viral diseases and cancers, in-licensed from the US National Institutes of Health.

A privately held development stage medical device company focused on the development of innovative incisionless surgical systems, using high intensity focused ultrasound.

A privately held development stage medical device and biotechnology company focused on the development and commercialization of innovative technologies to customize optical properties of tissues for optical diagnostic and therapeutic applications.

A privately held development stage medical device company focused on the development of innovative products for the drug infusion markets.

A full service law firm, based in New York City, specializing in a wide variety of litigation, including cases with an emphasis on scientific and technical issues.

Privately held technology company focused on the development and commercialization of in-line oil refining technology to improve efficiency of operations and reduction in environmental emissions of diesel engines.

Privately held marketing communications company specializing in the development of web based technologies, programming tools and sophisticated design elements to create integrated, education-based solutions.